Free · 13,587 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Application of photobiomodulation in post-stroke dysfunctions: a literature review of recent clinical studies

These studies used transcranial PBM (tPBM) for cognitive impairment and aphasia, or peripheral PBM directly to paretic limbs to yield positive outcomes for limb spasticity and pain.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This literature review summarizes recent clinical studies of photobiomodulation, a non-invasive light therapy, in people with post-stroke motor, cognitive, and speech impairments. The authors report that transcranial and peripheral applications yielded positive outcomes in these studies, while noting that robust clinical evidence remains limited.

Who or what was studied
Stroke patients with post-stroke motor, cognitive, speech, or other functional impairments
Limits stated in the abstract
The abstract states that robust clinical evidence remains limited and that supporting animal evidence is preliminary.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Stroke patients often experience varying degrees of dysfunctions after a stroke, including motor, cognitive, speech, and other functional impairments. These post-stroke dysfunctions seriously affect the daily life and quality of life of patients. For many years, researchers have devoted themselves to finding non-invasive treatment methods to improve these functional deficits and enhance patients' quality of life. Photobiomodulation (PBM) is a non-invasive phototherapy, and can be an adjuvant therapy for various neurological disorders by promoting neurogenesis and eliciting anti-apoptotic, anti-inflammatory, and antioxidative responses. Existing animal experimental evidence indicates that PBM may offer potential benefits for stroke patients. However, robust clinical evidence remains limited. Recent clinical studies provided new data supporting the efficacy of PBM in post-stroke dysfunctions, including motor, cognitive, and speech impairments. These studies used transcranial PBM (tPBM) for cognitive impairment and aphasia, or peripheral PBM directly to paretic limbs to yield positive outcomes for limb spasticity and pain. This mini-review summarizes key findings from these studies and discusses the associated challenges and prospects of PBM.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Stroke, Transcranial photobiomodulation, Phototherapy. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies